Cancer Genetics Group

The Cancer Genetics Group of Laboratories studies the genetic causes, functional consequences and treatments of several different types of cancers.  Families with hereditary cancers have formed the basis for many of these studies which have now been broadened to include some of the more common ‘one off’ or sporadic tumours.

The Neuroendocrine Tumour Bank continues to be a major resource for much of our work.  Significant advances in our understanding of the genetic causes contributing to tumour formation have occurred through study of tumour specimens collected at surgery from generous patients.  Research students remain the lifeblood of our research effort. Training of these researchers of the future involves them spending periods working in the laboratories of our international collaborators.  This has helped us evolve to be able to describe the consequences of many of the genetic abnormalities that our prior work has uncovered.  These links contribute to our international competitiveness and have enabled our productivity to grow.

The work of the Cancer Genetics Group may be divided into 6 areas:

  1. Thyroid and Calcium Disorders Laboratory
  2. Functional Genomics Laboratory
  3. Gene Therapy Laboratory
  4. Cerebral Tumour Research Laboratory
  5. Familial Cancer Laboratory
  6. Associated Research Projects

 

 

Cancer Genetics Group Kerrie MacDonald, Jan Shaw, Debbie Marsh, Anne-Louise Richardson, Dindy Benn, Michael Han, Inge Stewart, Jonathon Parkinson, Julie McDonnell , Lucy Richards, Bruce Robinson, Bridget Speller,Inge Mertens

 

 

 

 

Updated 23 August 2005